{"nctId":"NCT00510484","briefTitle":"Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis","startDateStruct":{"date":"2007-11"},"conditions":["Cystic Fibrosis"],"count":35,"armGroups":[{"label":"A","type":"EXPERIMENTAL","interventionNames":["Drug: Pancrelipase Delayed Release"]},{"label":"B","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo Comparator"]}],"interventions":[{"name":"Pancrelipase Delayed Release","otherNames":[]},{"name":"Placebo Comparator","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Confirmed CF diagnosis by two positive chloride sweat tests or gene analysis\n* Confirmed PEI by historical CFA \\< 70% without supplementation or current or historical fecal elastase \\< 50Âµg/g stool (within the last 12 months)\n* Subjects of 12 years or older\n* Currently receiving treatment with a commercially available pancreatic enzyme product on a stable dose for more than 3 months\n* Clinically stable condition without evidence of acute respiratory disease or any other acute condition\n* Females of child-bearing potential must agree to continue using a medically acceptable method of birth control\n\nExclusion Criteria:\n\n* Ileus or acute abdomen\n* History of fibrosing colonopathy\n* History of distal ileal obstruction syndrome within 6 months of enrollment\n* Use of an immunosuppressive drug\n* Any type of malignancy involving the digestive tract in the last 5 years\n* Known infection with HIV","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Coefficient of Fat Absorption (%)","description":"This coefficient is calculated from fat intake and fat excretion : 100\\*\\[fat intake-fat excretion\\]/fat intake. Stools were collected on 3 days during the 5 days treatment period. Higher values indicate a better response.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88.62","spread":"6.62"},{"groupId":"OG001","value":"49.78","spread":"18.33"}]}]}]},{"type":"SECONDARY","title":"Coefficient of Nitrogen Absorption (%)","description":"This coefficient is calculated from nitrogen intake and nitrogen excretion : 100\\*\\[nitrogen intake-nitrogen excretion\\]/nitrogen intake. Stools were collected on 3 days during the 5 days treatment period. Higher values indicate a better response.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"85.06","spread":"6.38"},{"groupId":"OG001","value":"49.99","spread":"17.14"}]}]}]},{"type":"SECONDARY","title":"Total Fat Excretion (Grams)","description":"Total amount of fat excreted during the stool collection period. Stools were collected on 3 days during the 5 days treatment period. Lower values indicate a better response.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"57.7","spread":"46.1"},{"groupId":"OG001","value":"243.2","spread":"112.7"}]}]}]},{"type":"SECONDARY","title":"Total Stool Weight (Grams)","description":"Total weight of the stools collected during the stool collection period. Stools were collected on 3 days during the 5 days treatment period. Lower values indicate a better response.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"630.1","spread":"306.9"},{"groupId":"OG001","value":"1582.5","spread":"664.5"}]}]}]},{"type":"SECONDARY","title":"Stool Frequency","description":"Stool frequency is the average of the daily number of stools recorded during the treatment period. Lower values indicate a better response.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.75","spread":"0.81"},{"groupId":"OG001","value":"2.88","spread":"1.18"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Percentage of Days With Formed/Normal Stools.","description":"The percentage of days with formed/normal stools is calculated from the diary during the treatment period: 100\\*(number of days with formed/normal stools/number of days with any stool). Higher values indicate a better response.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"75.0","spread":"30.0"},{"groupId":"OG001","value":"23.9","spread":"27.8"}]}]}]},{"type":"SECONDARY","title":"Percentage of Days With no Flatulence.","description":"The percentage of days with no flatulence is calculated from the diary during the treatment period: 100\\*(number of days with no flatulence/number of days recorded in diary). Higher values indicate a better response.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41.6","spread":"41.9"},{"groupId":"OG001","value":"23.1","spread":"35.1"}]}]}]},{"type":"SECONDARY","title":"Percentage of Days With no Abdominal Pain.","description":"The percentage of days with no abdominal pain is calculated from the diary during the treatment period: 100\\*(number of days with no abdominal pain / number of days recorded in diary). Higher values indicate a better response.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"90.3","spread":"16.8"},{"groupId":"OG001","value":"59.1","spread":"43.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":32},"commonTop":["Gastrointestinal and abdominal pain (Excl oral and throat)","Flatulence, Bloating and Distension","Headaches NEC","Faeces abnormal","Physical Examination Procedures"]}}}